Similar articles for PMID: 15181128

Year	Number of Results
1978	1
1980	1
1981	1
1983	1
1984	1
1985	1
1986	1
1987	7
1988	2
1989	7
1990	5
1991	4
1992	6
1993	4
1994	7
1995	7
1996	7
1997	3
1998	10
1999	8
2000	9
2001	7
2002	10
2003	10
2004	11
2005	7
2006	11
2007	4
2008	9
2009	11
2010	10
2011	9
2012	15
2013	14
2014	7
2015	10
2016	13
2017	15
2018	10
2019	8
2020	6
2021	6
2022	8
2023	2
2024	0

1

Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases.

Kuroda S, Shiga T, Ishikawa T, Houkin K, Narita T, Katoh C, Tamaki N, Iwasaki Y. Kuroda S, et al. J Nucl Med. 2004 Jun;45(6):943-9. J Nucl Med. 2004. PMID: 15181128 Free article. Clinical Trial.

2

Cerebral oxygen metabolism and neuronal integrity in patients with impaired vasoreactivity attributable to occlusive carotid artery disease.

Kuroda S, Shiga T, Houkin K, Ishikawa T, Katoh C, Tamaki N, Iwasaki Y. Kuroda S, et al. Stroke. 2006 Feb;37(2):393-8. doi: 10.1161/01.STR.0000198878.66000.4e. Epub 2005 Dec 29. Stroke. 2006. PMID: 16385090

3

Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease.

Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M. Yamauchi H, et al. Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1349-56. doi: 10.1007/s00259-002-0899-x. Epub 2002 Aug 6. Eur J Nucl Med Mol Imaging. 2002. PMID: 12271418 Clinical Trial.

4

Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamide and cerebral blood flow SPECT imaging.

Kuroda H, Ogasawara K, Suzuki T, Chida K, Aso K, Kobayashi M, Yoshida K, Terasaki K, Fujiwara S, Kubo Y, Ogawa A. Kuroda H, et al. Clin Nucl Med. 2012 Mar;37(3):235-40. doi: 10.1097/RLU.0b013e31823ea69f. Clin Nucl Med. 2012. PMID: 22310248

5

Diastolic blood pressure influences cerebrovascular reactivity measured by means of 123I-iodoamphetamine brain single photon emission computed tomography in medically treated patients with occlusive carotid or middle cerebral artery disease.

Kimura Y, Oku N, Kajimoto K, Katoh H, Tanaka MR, Takasawa M, Imaizumi M, Kitagawa K, Hori M, Hatazawa J. Kimura Y, et al. Ann Nucl Med. 2006 Apr;20(3):209-15. doi: 10.1007/BF03027432. Ann Nucl Med. 2006. PMID: 16715952

6

Clinical implication and prognosis of normal baseline cerebral blood flow with impaired vascular reserve in patients with major cerebral artery occlusive disease.

Isozaki M, Arai Y, Kudo T, Kiyono Y, Kobayashi M, Kubota T, Kikuta K, Okazawa H. Isozaki M, et al. Ann Nucl Med. 2010 Jun;24(5):371-7. doi: 10.1007/s12149-010-0367-9. Epub 2010 Mar 18. Ann Nucl Med. 2010. PMID: 20238185 Clinical Trial.

7

Acetazolamide reactivity on 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters.

Hirano T, Minematsu K, Hasegawa Y, Tanaka Y, Hayashida K, Yamaguchi T. Hirano T, et al. J Cereb Blood Flow Metab. 1994 Sep;14(5):763-70. doi: 10.1038/jcbfm.1994.97. J Cereb Blood Flow Metab. 1994. PMID: 8063872

8

Central benzodiazepine receptor binding potential and CBF images on SPECT correlate with oxygen extraction fraction images on PET in the cerebral cortex with unilateral major cerebral artery occlusive disease.

Chida K, Ogasawara K, Kuroda H, Aso K, Kobayashi M, Fujiwara S, Yoshida K, Terasaki K, Ogawa A. Chida K, et al. J Nucl Med. 2011 Apr;52(4):511-8. doi: 10.2967/jnumed.110.084186. Epub 2011 Mar 18. J Nucl Med. 2011. PMID: 21421729 Free article.

9

Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.

Okazawa H, Yamauchi H, Toyoda H, Sugimoto K, Fujibayashi Y, Yonekura Y. Okazawa H, et al. J Nucl Med. 2003 Dec;44(12):1875-83. J Nucl Med. 2003. PMID: 14660711 Free article. Clinical Trial.

10

PET OEF reactivity for hemodynamic compromise in occlusive vascular disease.

Nemoto EM, Yonas H, Pindzola RR, Kuwabara H, Sashin D, Chang Y, Jovin T. Nemoto EM, et al. J Neuroimaging. 2007 Jan;17(1):54-60. doi: 10.1111/j.1552-6569.2006.00080.x. J Neuroimaging. 2007. PMID: 17238870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

269 results

Results by year